13
Further Pharmacological and Genetic Evidence for the Efficacy of PlGF Inhibition in Cancer and Eye Disease Sara Van de Veire, Ingeborg Stalmans, Femke Heindryckx, Hajimu Oura, Annemilaï Tijeras-Raballand, Thomas Schmidt, Sonja Loges, Imke Albrecht, Bart Jonckx, Stefan Vinckier, Christophe Van Steenkiste, Sònia Tugues, Charlotte Rolny, Maria De Mol, Daniela Dettori, Patricia Hainaud, Lieve Coenegrachts, Jean-Olivier Contreres, Tine Van Bergen, Henar Cuervo, Wei-Hong Xiao, Carole Le Henaff, Ian Buysschaert, Behzad Kharabi Masouleh, Anja Geerts, Tibor Schomber, Philippe Bonnin, Vincent Lambert, Jurgen Haustraete, Serena Zacchigna, Jean-Marie Rakic, Wladimiro Jiménez, Agnes Noël, Mauro Giacca, Isabelle Colle, Jean-Michel Foidart, Gerard Tobelem, Manuel Morales-Ruiz, José Vilar, Patrick Maxwell, Stanley A. Vinores, Geert Carmeliet, Mieke Dewerchin, Lena Claesson-Welsh, Evelyne Dupuy, Hans Van Vlierberghe, Gerhard Christofori, Massimiliano Mazzone, Michael Detmar, Désiré Collen, Peter Carmeliet Cell Volume 141, Issue 1, Pages 178-190 (April 2010) DOI: 10.1016/j.cell.2010.02.039 Copyright © 2010 Elsevier Inc. Terms and Conditions

Further Pharmacological and Genetic Evidence for the Efficacy of PlGF Inhibition in Cancer and Eye Disease Sara Van de Veire, Ingeborg Stalmans, Femke

Embed Size (px)

Citation preview

Page 1: Further Pharmacological and Genetic Evidence for the Efficacy of PlGF Inhibition in Cancer and Eye Disease Sara Van de Veire, Ingeborg Stalmans, Femke

Further Pharmacological and Genetic Evidence for the Efficacy of PlGF Inhibition in Cancer and Eye Disease 

Sara Van de Veire, Ingeborg Stalmans, Femke Heindryckx, Hajimu Oura, Annemilaï Tijeras-Raballand, Thomas Schmidt, Sonja Loges, Imke Albrecht, Bart Jonckx, Stefan Vinckier, Christophe Van Steenkiste, Sònia Tugues, Charlotte Rolny, Maria De Mol, Daniela Dettori, Patricia Hainaud, Lieve Coenegrachts, Jean-Olivier Contreres, Tine Van Bergen, Henar Cuervo, Wei-Hong Xiao, Carole Le Henaff, Ian Buysschaert, Behzad Kharabi Masouleh, Anja Geerts, Tibor Schomber, Philippe Bonnin, Vincent Lambert, Jurgen Haustraete, Serena Zacchigna, Jean-Marie Rakic, Wladimiro Jiménez, Agnes Noël, Mauro Giacca, Isabelle Colle, Jean-Michel Foidart, Gerard Tobelem,

Manuel Morales-Ruiz, José Vilar, Patrick Maxwell, Stanley A. Vinores, Geert Carmeliet, Mieke Dewerchin, Lena Claesson-Welsh, Evelyne Dupuy, Hans Van Vlierberghe, Gerhard Christofori, Massimiliano Mazzone, Michael Detmar, Désiré Collen, Peter Carmeliet  

Cell Volume 141, Issue 1, Pages 178-190 (April 2010)

DOI: 10.1016/j.cell.2010.02.039

Copyright © 2010 Elsevier Inc. Terms and Conditions

Page 2: Further Pharmacological and Genetic Evidence for the Efficacy of PlGF Inhibition in Cancer and Eye Disease Sara Van de Veire, Ingeborg Stalmans, Femke

Figure 1

Cell 2010 141, 178-190DOI: (10.1016/j.cell.2010.02.039) Copyright © 2010 Elsevier Inc. Terms and Conditions

Page 3: Further Pharmacological and Genetic Evidence for the Efficacy of PlGF Inhibition in Cancer and Eye Disease Sara Van de Veire, Ingeborg Stalmans, Femke

Figure 2

Cell 2010 141, 178-190DOI: (10.1016/j.cell.2010.02.039) Copyright © 2010 Elsevier Inc. Terms and Conditions

Page 4: Further Pharmacological and Genetic Evidence for the Efficacy of PlGF Inhibition in Cancer and Eye Disease Sara Van de Veire, Ingeborg Stalmans, Femke

Figure 3

Cell 2010 141, 178-190DOI: (10.1016/j.cell.2010.02.039) Copyright © 2010 Elsevier Inc. Terms and Conditions

Page 5: Further Pharmacological and Genetic Evidence for the Efficacy of PlGF Inhibition in Cancer and Eye Disease Sara Van de Veire, Ingeborg Stalmans, Femke

Figure 4

Cell 2010 141, 178-190DOI: (10.1016/j.cell.2010.02.039) Copyright © 2010 Elsevier Inc. Terms and Conditions

Page 6: Further Pharmacological and Genetic Evidence for the Efficacy of PlGF Inhibition in Cancer and Eye Disease Sara Van de Veire, Ingeborg Stalmans, Femke

Figure 5

Cell 2010 141, 178-190DOI: (10.1016/j.cell.2010.02.039) Copyright © 2010 Elsevier Inc. Terms and Conditions

Page 7: Further Pharmacological and Genetic Evidence for the Efficacy of PlGF Inhibition in Cancer and Eye Disease Sara Van de Veire, Ingeborg Stalmans, Femke

Figure 6

Cell 2010 141, 178-190DOI: (10.1016/j.cell.2010.02.039) Copyright © 2010 Elsevier Inc. Terms and Conditions

Page 8: Further Pharmacological and Genetic Evidence for the Efficacy of PlGF Inhibition in Cancer and Eye Disease Sara Van de Veire, Ingeborg Stalmans, Femke

Figure 7

Cell 2010 141, 178-190DOI: (10.1016/j.cell.2010.02.039) Copyright © 2010 Elsevier Inc. Terms and Conditions

Page 9: Further Pharmacological and Genetic Evidence for the Efficacy of PlGF Inhibition in Cancer and Eye Disease Sara Van de Veire, Ingeborg Stalmans, Femke

Figure S1

Cell 2010 141, 178-190DOI: (10.1016/j.cell.2010.02.039) Copyright © 2010 Elsevier Inc. Terms and Conditions

Page 10: Further Pharmacological and Genetic Evidence for the Efficacy of PlGF Inhibition in Cancer and Eye Disease Sara Van de Veire, Ingeborg Stalmans, Femke

Figure S2

Cell 2010 141, 178-190DOI: (10.1016/j.cell.2010.02.039) Copyright © 2010 Elsevier Inc. Terms and Conditions

Page 11: Further Pharmacological and Genetic Evidence for the Efficacy of PlGF Inhibition in Cancer and Eye Disease Sara Van de Veire, Ingeborg Stalmans, Femke

Figure S3

Cell 2010 141, 178-190DOI: (10.1016/j.cell.2010.02.039) Copyright © 2010 Elsevier Inc. Terms and Conditions

Page 12: Further Pharmacological and Genetic Evidence for the Efficacy of PlGF Inhibition in Cancer and Eye Disease Sara Van de Veire, Ingeborg Stalmans, Femke

Figure S4

Cell 2010 141, 178-190DOI: (10.1016/j.cell.2010.02.039) Copyright © 2010 Elsevier Inc. Terms and Conditions

Page 13: Further Pharmacological and Genetic Evidence for the Efficacy of PlGF Inhibition in Cancer and Eye Disease Sara Van de Veire, Ingeborg Stalmans, Femke

Figure S5

Cell 2010 141, 178-190DOI: (10.1016/j.cell.2010.02.039) Copyright © 2010 Elsevier Inc. Terms and Conditions